TUESDAY, DECEMBER 12, 2017

Takeda Pharmaceutical Company

1 Takeda Pkwy
Deerfield, IL - 60015

Takeda Pharmaceutical Company News

Takeda speeds new treatments for neglected tropical diseases

Takeda Pharmaceutical Company Limited recently announced that it has joined WIPO Re:Search, which is a consortium that is dedicated to speeding the research and development of new vaccines, drugs and diagnostics for neglected tropical diseases, tuberculosis (TB) and malaria. Read More »

Takeda consolidates US vaccine sites in Boston

Takeda Pharmaceutical Co. Ltd. recently announced that it will begin to consolidate the company’s Vaccine Business Unit (VBU) operations throughout the Boston and Cambridge area. Read More »

Takeda to distribute seasonal flu vaccines in Japan

Takeda Pharmaceutical Co. Ltd. recently announced that it has partnered with the Chemo-Sero-Therapeutic Research Institute to distribute Kaketsuken’s seasonal influenza vaccine throughout Japan. Read More »

Takeda transfers HPV vaccine license to Kaketsuken

Takeda Pharmaceutical Company, Ltd., has recently transferred its license agreement for a vaccine for human papillomavirus (HPV) to Kaketsuken, the Chemo-Sero-Therapeutic Research Institute. Read More »

Takeda halts DTaP-sIP vaccine development

Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan and Asia, recently announced that it has discontinued the development of TAK-361S vaccine, which was in clinical development Phase 2. Read More »